Lupin launches Tadalafil Tablets

February 13, 2019 | Wednesday | News

It is the generic equivalent of Eli Lilly’s Adcirca Tablets 20mg

Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Tadalafil Tablets USP 20mg is the generic equivalent of Eli Lilly’s Adcirca Tablets 20mg. It is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

Tadalafil Tablets, 20mg had annual sales of approximately US$474.3 million in the US (IQVIA MAT December 2018).